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Abstract 
Among the array of nanomaterials, carbon nanotubes have shown great potential as drug 
carriers in the field of nanomedicine, owing to their attractive physicochemical structure, 
which facilitates functionalization of therapeutic molecules onto their external walls or being 
encapsulated inside the tubes. The aim of this preliminary study was to formulate betulinic 
acid (BA), a poorly water-soluble drug, in oxidized multiwalled carbon nanotubes (MWCNT-
COOH) for enhanced delivery efficiency into cancer cells with reduced cytotoxicity. The 
synthesized MWCNT-BA nanocomposite was characterized using ultraviolet-visible, Fourier 
transform infrared, thermogravimetric analysis, powder X-ray diffraction, and field emission 
scanning electron microscopy techniques. The loading of BA in MWCNT-COOH nanocarrier 
was estimated to be about 14.5%–14.8% (w/w), as determined by ultraviolet-visible and 
thermogravimetric analysis. Fourier transform infrared study shows that the peaks of the 
resulting MWCNT-BA nanocomposite correlate to the characteristic functional groups of BA 
and MWCNT-COOH. The powder X-ray diffraction results confirmed that the tubular 
structures of MWCNT-COOH were not affected by the drug loading mechanism of BA. The 
release profiles demonstrated that approximately 98% of BA could be released within 22 
hours by phosphate-buffered saline solution at pH 7.4 compared with about 22% within 24 
hours at pH 4.8. The biocompatibility studies revealed that MWCNT-BA at concentrations 
<50 µg/mL expressed no cytotoxicity effects for mouse embryo fibroblast cells after 72 hours 
of treatment. The anticancer activity of MWCNT-BA was observed to be more sensitive to 
human lung cancer cell line when compared with human liver cancer cell line, with half 
maximal inhibitory concentration values of 2.7 and 11.0 µg/mL, respectively. Our findings 
form a fundamental platform for further investigation of the MWCNT-BA formulation 
against different types of cancer cells. 
 
Keyword: Multiwalled carbon nanotubes (MWCNTs); Drug delivery; Controlled release; 
Cytotoxicity; A549 cell line; HepG2 cell line 
  
 
